In 2023, Respiratory System Medicine sales in Germany were at 4.35 billion USD PPP. Looking to the future, sales are projected to increase steadily from 2024 through 2028, with values expected to rise from 4.52 billion USD in 2024 to 5.21 billion USD by 2028. The year-on-year growth rate from 2024 onwards reflects a consistent upward trend, with notable increases each year: 3.76% in 2025, 3.84% in 2026, 3.49% in 2027, and 3.37% in 2028. The compound annual growth rate (CAGR) expected over this five-year period is approximately 3.84%.
Future trends to watch for include technological advancements in medicine manufacturing, changes in government healthcare policies, increased awareness and treatment of respiratory conditions, and potential unforeseen impacts from global health events. Additionally, the increasing prevalence of respiratory diseases due to environmental factors may further stimulate market growth.
